TP53 and prostate cancer: For example, the MAPK pathway was suppressed by decreasing MMP9 expression by CAP in cervical cancer cells (Li et al., 2016), and p53 or p21 was dysregulated by CAP in prostate cancer cells (Weiss et al., 2015).